Connect Biopharma Holdings Limited

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Connect Biopharma Holdings Limited
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Cayman Islands
Headquarters city
SAN Diego
Headquarters state / province
California
Headquarters country
China
Fiscal year end
December
Ticker symbol
CNTB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001835268

Board of directors

Follow this board

Chief executives

Barry D. Quart · Chief Executive Officer
Since March 2026

Board connections

5 of this board's directors also sit on 9 other boards.

Network of Connect Biopharma Holdings Limited's board connections Alaunos Therapeutics Inc. Alaunos Therapeutics I... Atara Biotherapeutics Inc. Atara Biotherapeutics... Calidi Biotherapeutics Inc. Calidi Biotherapeutics... Elicio Therapeutics Inc. Elicio Therapeutics In... Erasca Inc. Erasca Inc. Heron Therapeutics Inc. Heron Therapeutics Inc... Kiniksa Pharmaceuticals International plc Kiniksa Pharmaceutical... Kyntra Bio Inc. Kyntra Bio Inc. Serina Therapeutics Inc. Serina Therapeutics In... Barry D. Quart Barry D. Quart James A. Schoeneck James A. Schoeneck James Huang James Huang Jean I. Liu Jean I. Liu Karen J. Wilson Karen J. Wilson Connect Biopharma Holdings...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$4,374,000
2 purchases by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 30, 2026 Jean I. Liu Director Grant or award +6,718 — —
Jun 30, 2026 Kleanthis Gabriel Xanthopoulos Director Grant or award +3,738 — —
May 29, 2026 James Huang Director Open-market purchase +150,000 $2.48 $372,000
Mar 31, 2026 Kleanthis Gabriel Xanthopoulos Director Grant or award +2,816 — —
Mar 31, 2026 Jean I. Liu Director Grant or award +5,061 — —
Mar 31, 2026 James Huang Director Open-market purchase +1,160,000 $3.45 $4,002,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.